中文 | English
Return
Total: 530 , 1/53
Show Home Prev Next End page: GO
Author:(wei Zi ZHANG)

3.Preparation of Platycodin-D for Reference Substance

Wei LI ; Jing ZHANG ; Huiping LI ; Zi WANG ; Yinan ZHENG

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-

4.Nerve Stem Cells Orientation Differentiation in Neonatal Rat Hippocampus Induced by Brain-Derived Neurotrophic Factor in Vitro

jun-feng, YU ; zi-jin, YANG ; wei-hong, ZHANG

Journal of Applied Clinical Pediatrics 2006;0(14):-

5.Research progress of the role of PPARγ in autoimmune diseases

Yan YANG ; Yu ZHOU ; Ya-zi WEI ; Tian-tai ZHANG

Acta Pharmaceutica Sinica 2022;57(10):3124-3132

6.The latest research progress of torpor occurrence mechanism

Zi-yu ZHU ; Jian-wei JIANG ; Jian-jun ZHANG

Acta Pharmaceutica Sinica 2021;56(6):1532-1536

7.Problematic issues in clinical trials of mesenchymal stem cells and unraveling strategies.

Wei-Wei ZHANG ; Zi-Kuan GUO

Journal of Experimental Hematology 2007;15(4):901-904

8.Clinical analysis of ligustrazine in the treatment of chronic renal failure

wei Zi CHEN ; Wei ZHANG

Chinese Journal of Biochemical Pharmaceutics 2017;37(10):223-224

9.The diagnosis and treatment of ischemic bowel disease,experience in 73 cases

Wei FU ; Chao-Lai MA ; Zi-Shun ZHANG ; Min LYU ; Xue-Song YANG ; Tong-Lin ZHANG

Chinese Journal of General Surgery 1993;0(02):-

10.Effect of hemodialysis on pharmacokinetics of sparfIoxacin in the patients with chronic renal failure

Zhu LIANG ; Rong-Zi SHAO ; Ying-Wei ZHANG ; Ei-Ping ZHANG ; Chen YUAN ;

Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 530 , 1/53 Show Home Prev Next End page: GO